Showing results (371-380 of 401) with videos related to

Sort By:
Pageof 41
Human Molecular Genetics|October 31, 2014
Expression inactivation of SMARCA4 by microRNAs in lung tumorsIsabel F Coira, Eva E Rufino-Palomares, Octavio A Romero, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Public HealthHaakon B Nygaard, Sylvie Belleville, Nicole D Anderson, et al.
The Journal of Biological Chemistry|April 19, 2024
Defining the mechanism of galectin-3-mediated TGF-β1 activation and its role in lung fibrosisJessica F Calver, Nimesh R Parmar, Gemma Harris, et al.
Journal of Medicinal Chemistry|September 13, 2024
Discovery and Development of Highly Potent and Orally Bioavailable Nonpeptidic αvβ6 Integrin InhibitorsPanayiotis A Procopiou, John Barrett, Matthew H J Crawford, et al.
Biorxiv : the Preprint Server for Biology|September 11, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Cell Cycle (Georgetown, Tex.)|May 12, 2015
Estrogen withdrawal, increased breast cancer risk and the KRAS-variantTerri P McVeigh, Song-Yi Jung, Michael J Kerin, et al.
Plos Biology|August 13, 2013
Anthranilate fluorescence marks a calcium-propagated necrotic wave that promotes organismal death in C. elegansCassandra Coburn, Erik Allman, Parag Mahanti, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 26, 2013
Pharmacological characterization of GSK573719 (umeclidinium): a novel, long-acting, inhaled antagonist of the muscarinic cholinergic receptors for treatment of pulmonary diseasesMichael Salmon, Mark A Luttmann, James J Foley, et al.
Cell Reports|November 22, 2023
Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53Jonathan D Lee, Bridget L Menasche, Maria Mavrikaki, et al.
Pageof 41